Pages that link to "Q36015736"
Jump to navigation
Jump to search
The following pages link to Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial (Q36015736):
Displaying 50 items.
- Interventions for preventing falls in older people living in the community (Q24200464) (← links)
- Interventions for preventing falls in older people living in the community (Q24241432) (← links)
- Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences (Q26767412) (← links)
- Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers? (Q26775758) (← links)
- Clinical trial design for older people--time for a rethink (Q26824559) (← links)
- Muscle function in COPD: a complex interplay (Q26865732) (← links)
- The renin-angiotensin system and prevention of age-related functional decline: where are we now? (Q28085528) (← links)
- Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II). (Q31132903) (← links)
- Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial (Q33615993) (← links)
- ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. (Q33636677) (← links)
- Are we closer to having drugs to treat muscle wasting disease? (Q33741103) (← links)
- Optimizing the benefits of exercise on physical function in older adults. (Q33779905) (← links)
- The implication of frailty on preoperative risk assessment (Q33825857) (← links)
- Frailty in elderly people (Q33902569) (← links)
- Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review (Q33956866) (← links)
- Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations (Q33962042) (← links)
- Optimal management of sarcopenia (Q34121822) (← links)
- Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update (Q34121836) (← links)
- Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies (Q34157292) (← links)
- Perioperative frailty (Q34278764) (← links)
- A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. (Q34299825) (← links)
- Role of frailty assessment in patients undergoing cardiac interventions (Q34333218) (← links)
- Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? (Q34886182) (← links)
- Determinants of frailty: the added value of assessing medication (Q35506930) (← links)
- One size may not fit all: anti-aging therapies and sarcopenia (Q35740777) (← links)
- Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis (Q35749354) (← links)
- Novel intriguing strategies attenuating to sarcopenia (Q35829811) (← links)
- Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial (Q35908858) (← links)
- Disability and incident coronary heart disease in older community-dwelling adults: the Three-City Study (Q36015682) (← links)
- Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study (Q36076367) (← links)
- Medication Use and Functional Status Decline in Older Adults: A Narrative Review (Q36099587) (← links)
- Interaction between bone and muscle in older persons with mobility limitations (Q36100758) (← links)
- Successful aging: Advancing the science of physical independence in older adults. (Q36322590) (← links)
- FRAILTY: A Report from the 3(rd) Joint Workshop of IAGG/WHO/SFGG, Athens, January 2012 (Q36450567) (← links)
- Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women (Q36463353) (← links)
- Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study. (Q36537163) (← links)
- Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults (Q36690359) (← links)
- Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise (Q36764607) (← links)
- Effect of spironolactone on physical performance in older people with self-reported physical disability (Q36963464) (← links)
- Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study. (Q37000459) (← links)
- The effects of antihypertensive medications on physical function (Q37056799) (← links)
- Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration (Q37099711) (← links)
- Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia (Q37138465) (← links)
- Sarcopenia: diagnosis and treatment (Q37211847) (← links)
- Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms (Q37211861) (← links)
- Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational Study (Q37350734) (← links)
- Neuro-hormonal effects of physical activity in the elderly (Q37404953) (← links)
- Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease. (Q37490167) (← links)
- Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia (Q37573464) (← links)
- ACE and response to pulmonary rehabilitation in COPD: two observational studies. (Q37704113) (← links)